Richard Chin, M.D. is a Board Certified internist with extensive expertise in drug development. He has overseen over 40 Investigational New Drug Applications for new molecular entities and new indications, as well as eight New Drug Applications/Biologic License Applications. As chief executive officer of OneWorld Health, Dr. Chin writes about a new partnership to fight one of the most pervasive killers of children worldwide.
